Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2009
06/10/2009CN101450038A Nicarbazin and ethopabate nano suspension agent and preparation method thereof
06/10/2009CN101450037A Xylitol intravenous injection liquid and preparation method thereof
06/10/2009CN101450036A Anti-cancer sustained release agent loaded with glucocorticoid and chemical curing medicine
06/10/2009CN101450035A Double sustained release biological agent for tumor local ablation therapy
06/10/2009CN100497445C Cellulose powder
06/10/2009CN100497370C Bursopoietin extracting method and its use in disease treating and immune
06/10/2009CN100496693C Method for the production of particles
06/10/2009CN100496621C Methods and devices for the treatment of intervertebral discs
06/10/2009CN100496620C Medical non-crosslinked pressure-sensitive adhesive composition, process for producing medical non-crosslinked pressure-sensitive adhesive composition and medical adhesive sheet
06/10/2009CN100496611C Preparations for topical skin use and treatment
06/10/2009CN100496608C Medical aerosol formulations
06/10/2009CN100496596C Improved Chinese medicinal paste for arthralgia and its preparation
06/10/2009CN100496587C Pills for mammary gland disease and its preparation
06/10/2009CN100496579C Antipruritic compositions and compositions for wound healing
06/10/2009CN100496575C Plaster for treating protrusion of the lumber intervertebral discs
06/10/2009CN100496568C Jin-Gui-Shen-Qi capsule preparation method
06/10/2009CN100496563C Combination of natural products for curing hyperlipemia, atherosclerosis and relevant disease
06/10/2009CN100496542C Chinese traditional medicine composition for treating arthralgia syndrome of cervical spondylopathy and its preparation
06/10/2009CN100496530C Traditional Chinese medicinal composition for treating coronary heart disease and its preparation method
06/10/2009CN100496526C Preparation of soft capsule of Chinese traditional medicine for treating rheumatism and preparation method
06/10/2009CN100496525C Technique of extracting acitve ingredient from roots, stems and leaves from artichoke and application
06/10/2009CN100496512C Pearl suspension
06/10/2009CN100496511C Preparation method of Bingling ointment for curing burn and scald
06/10/2009CN100496509C Carbon monoxide product and its uses for treating ileus
06/10/2009CN100496505C Nano emulsion containing ginsenoside, preparation method and usage
06/10/2009CN100496503C Nano emulsion containing ginsenoside, preparation method and usage
06/10/2009CN100496486C Hard-soluble medicine release-controlled formulation
06/10/2009CN100496472C Topical compositions and methods for treating pain
06/10/2009CN100496469C Gatifloxacin capsules and method of preparing the same
06/10/2009CN100496468C Chitin embedded or encapsulated capsule
06/10/2009CN100496467C Soft capsule containing extract of tree peony bar and cape jasmine and its preparation method
06/10/2009CN100496466C Compound licorice dripping pill preparation and its preparation process
06/10/2009CN100496465C Chinese medicinal preparation for treating gynecopathy and production thereof
06/10/2009CN100496464C Folic acid freeze-dried injection and preparation thereof
06/10/2009CN100496463C Omeprazole sodium freeze-dried powder injection and preparing method thereof
06/10/2009CN100496462C Method for producing multiple emulsions that are stable in storage
06/10/2009CN100496461C Refining method of ginko total flavone and method for preparing ginko damo injection
06/10/2009CN100496460C Externally applied agent for treating purulent diseases
06/10/2009CN100496459C Compound licorice root medicinal preparation and preparing method thereof
06/10/2009CN100496458C Method of forming aerosol for inhalation delivery
06/10/2009CN100496448C Oil-in-water emulsion composition
06/10/2009CN100496446C Process for making pre-formed objects
06/10/2009CN100496284C Use of branched malto-dextrins as granulation binders
06/10/2009CN100496244C Nodulisporic acid derivative spot-on formulations for killing parasites
06/09/2009US7544805 Hydrophobic; storage stability; coprecipitate of amorphous montelukast sodium and lactose prepared by freeze-drying and pressing at 10,000 Kg/cm3 for 1 minute; spray drying from an aqueous solution; relatively high bulk density; materials handling
06/09/2009US7544718 Continuous process for emulsification of solutions for skins or cosmetics and adding perfumes after homogenizing in a continuous process
06/09/2009US7544674 For the treatment of a hyperpigmented skin condition
06/09/2009US7544673 Blends comprising ethylene-vinyl acetate copolymer and poly(alkyl(meth)acrylates or poly(aromatic(meth)acrylates); implantable medical device; permits stents releasing the bioactive agent over time in vivo; provides clear coats, durability, biocompatibility, and release kinetics; drug delivery device
06/09/2009US7544671 Hyaluronan is combined with a polyglycol, such as polyethylene glycol; preparations may maintain their viscosity and lubricity for extended time periods (e.g., 2 years) without requiring refrigeration or special storage conditions
06/09/2009US7544670 HoxD3, HoxA3 and HoxB3 compositions and methods for improved wound healing
06/09/2009US7544656 Long acting injectable insulin composition and methods of making and using thereof
06/09/2009US7544496 Process for making organic/inorganic composites
06/09/2009US7544374 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
06/09/2009US7544373 Minocycline oral dosage forms for the treatment of acne
06/09/2009US7544372 Such as capsules/beads of cyclobenzaprine hydrochloride
06/09/2009US7544371 Matrix controlled diffusion systems; based on silicone-containing monomers and are sized and configured for back of the eye delivery; eye disorders
06/09/2009US7544370 Mixture with cellulose ethers and water; antiulcer agents
06/09/2009US7544369 pulmonary administration of a liposomal/complexed antiinfective to treat or ameliorate a pulmonary infection in a cystic fibrosis patient; administrated amount is 50% or less of the comparative free drug amount
06/09/2009US7544367 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles
06/09/2009US7544364 reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release; side effect reduction
06/09/2009US7544363 Exhibit probiotic activity in aerobic conditions; does not contribute to the production of future generation of antibiotic resistant pathogens
06/09/2009US7544361 A fusion monomer of fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a mucous membrane-binding protein monomer; industrial scale; purification efficiency; recombinant mucosal vaccine; intestinal immunization by oral administration
06/09/2009US7544359 Antiischemic agents; anticholesterol agents; cardiovascular disorders
06/09/2009US7544348 Liquid formulations for the prevention and treatment of mucosal diseases and disorders
06/09/2009US7544327 A stimulating source (laser), a transducer having cantilever beam(s) upon which surface are immobilized antibodies against tartrate-resistant phosphatase, a signal detecting unit, and a signal processing unit for retrieving/analyzing signals; high-speed test; monotoring/preventing osteoporosis
06/09/2009US7544192 Sinus delivery of sustained release therapeutics
06/09/2009CA2444814C Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
06/09/2009CA2441007C Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
06/09/2009CA2410706C Composition and applicator for topical substance delivery
06/09/2009CA2403345C System for the controlled delivery of an active material to a dental site
06/09/2009CA2394232C Dual-release compositions of a cyclooxygenase-2-inhibitor
06/09/2009CA2382886C Benzamide formulation with histone deacetylase inhibitor activity
06/09/2009CA2377167C Multilayered tablet for administration of a fixed combination of tramadol and diclofenac
06/09/2009CA2352796C Milling process for the production of finely milled medicinal substances
06/09/2009CA2350659C Pharmaceutical composition for modified release insulin sensitiser
06/09/2009CA2338323C Two-piece capsule for receiving pharmaceutical preparations for powder inhalers
06/09/2009CA2326198C Cosolvent formulations
06/09/2009CA2276183C Pharmaceutical preparations of glutathione and methods of administration thereof
06/09/2009CA2196184C Sustained release preparation containing metal salt of a peptide
06/04/2009WO2009070761A1 Improved taxane delivery system
06/04/2009WO2009070609A2 Therapeutic targeting of il-6 using sirna in neutral liposomes
06/04/2009WO2009070589A1 Method and composition for treating pulmonary hemorrhage
06/04/2009WO2009070530A1 Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate
06/04/2009WO2009070431A1 Antihistamine/corticosteroid preparations for the treatment of atopic dermatitis
06/04/2009WO2009070282A1 Active nanoparticles and method of using
06/04/2009WO2009070211A1 Sustained release of apo a-i mimetic peptides and methods of producing them
06/04/2009WO2009070210A2 Sustained release of apo a-i mimetic peptides and methods for delivery in situ
06/04/2009WO2009070209A2 Sustained release of apo a-i mimetic peptides and methods of producing them
06/04/2009WO2009069991A2 Cellular therapeutic agent for incontinence of urine comprising stem cells originated from decidua or adipose
06/04/2009WO2009069643A1 Solid dispersion comprising 3-[5-[4-(cyclopentyloxy)- 2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid or salt thereof, or composition comprising the solid dispersion
06/04/2009WO2009069280A1 Method for producing granulated matter
06/04/2009WO2009069112A1 A delivery device for administering an active substance to a subject
06/04/2009WO2009069089A1 Levetiracetam controlled release composition
06/04/2009WO2009068922A2 Compositions containing capsaicinoids
06/04/2009WO2009068610A1 A method for producing adapalene gels
06/04/2009WO2009068545A1 Carrier particle for a microorganism or subunit thereof, pharmaceutical composition comprising such particles, method for preparation of this composition and its use in the treatment of animals
06/04/2009WO2009068301A1 Pharmaceutical formulation containing lipophilic drugs and milk as a solubilizing/dispersing agent and method for the preparation thereof
06/04/2009WO2009068278A2 A pharmaceutical composition
06/04/2009WO2009067734A1 Nanoemulsions
06/04/2009WO2009052295A3 Cerium oxide nanoparticles for treatment and prevention of alzheimer's disease, parkinson's disease, and disorders associated with free radical production and/or mitochondrial dysfunction